These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6410913)

  • 1. Cost benefit of pharmacist concurrent monitoring of cefazolin prescribing.
    Suzuki NT; Pelham LD
    Am J Hosp Pharm; 1983 Jul; 40(7):1187-91. PubMed ID: 6410913
    [No Abstract]   [Full Text] [Related]  

  • 2. Contribution of clinical pharmacists to cefazolin utilization.
    Witte KW; Hatoum HT; Hoon TJ
    Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cost-effectiveness of clinical pharmacist intervention on tobramycin prescribing.
    Khanderia U
    Hosp Formul; 1986 Oct; 21(10):1049-50, 1055-6. PubMed ID: 10311722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost benefit of pharmacy audit and nonrestrictive antibiotic policy.
    Ware GJ; Ford DJ
    N Z Med J; 1993 Apr; 106(954):160. PubMed ID: 8479665
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of a preprinted chart note on appropriate cefazolin prescribing.
    Haas CE; Paladino JA; Dibona JR
    Am J Hosp Pharm; 1986 Jul; 43(7):1754-6. PubMed ID: 3752116
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pharmacist impact on parenteral cephalosporin prescribing.
    Lawlor MC; Lucarotti RL
    Hosp Formul; 1983 Apr; 18(4):402-4, 407-8. PubMed ID: 10259512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug usage review and inventory analysis in promoting rational parenteral cephalosporin therapy.
    Simon WA; Thompson L; Campbell S; Lantos RL
    Am J Hosp Pharm; 1975 Nov; 32(11):1116-21. PubMed ID: 1190230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of control programs on cefazolin prescribing in a teaching hospital.
    Ma MY; Goldstein EJ; Meyer RD
    Am J Hosp Pharm; 1979 Aug; 36(8):1055-8. PubMed ID: 484564
    [No Abstract]   [Full Text] [Related]  

  • 9. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter survey of cefazolin usage.
    Steckel SD; Siskin SB
    Hosp Formul; 1981 Nov; 16(11):1284-6, 1291-3. PubMed ID: 10253176
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of an education program on cefazolin prescribing.
    Blain L; O'Brodovich M
    Can J Hosp Pharm; 1989 Apr; 42(2):69-71. PubMed ID: 10292923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an aminoglycoside kinetic service on aminoglycoside use in a community hospital.
    Cahill RJ; Myers RM; Bauer LA; Alston RM
    Hosp Pharm; 1986 Aug; 21(8):734-7. PubMed ID: 10277582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs.
    Abramowitz PW; Nold EG; Hatfield SM
    Am J Hosp Pharm; 1982 Jul; 39(7):1176-80. PubMed ID: 7114059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a pharmacist/physician cooperative target drug monitoring program on prophylactic antibiotic prescribing in obstetrics and gynecology.
    Michael KA; Henderson PL; Newman RB; Blackwelder EN; Caldwell RD
    Hosp Pharm; 1992 Mar; 27(3):213-6. PubMed ID: 10116721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an inpatient decentralized pharmacy team program in an HMO setting.
    Chamberlain MA; Stergachis A; Sachse-Bray B; Woodard L; Gibson D
    Hosp Pharm; 1986 Aug; 21(8):742-7. PubMed ID: 10277583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost containment through restriction of cephalosporins.
    Britton HL; Schwinghammer TL; Romano MJ
    Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and cost-containment in hospital pharmacotherapy: state of the art and future directions.
    Soumerai SB; Avorn J
    Milbank Mem Fund Q Health Soc; 1984; 62(3):447-74. PubMed ID: 6433223
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacist-physician cooperation in the use of high-cost drugs.
    Oddis JA
    Resid Staff Physician; 1988 May; 34(6):13, 16. PubMed ID: 10287353
    [No Abstract]   [Full Text] [Related]  

  • 19. A pilot study of process and outcome assessment in antibiotic therapy.
    Ilersich AL; Rovers JP; Einarson TR
    Can J Hosp Pharm; 1991 Oct; 44(5):251-8, 270. PubMed ID: 10115579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting the cost-effective utilization of cefoxitin with a drug use education program.
    Wein PJ; Hoffman RP
    Hosp Formul; 1987 Mar; 22(3):299-306. PubMed ID: 10312016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.